NICE Technology Appraisal TA875 (2023) recommends semaglutide 2.4 mg (Wegovy) for use in adults with obesity or overweight with at least one weight-related comorbidity, when used alongside a reduced-calorie diet and increased physical activity
Patients should use this medication as prescribed according to their doctor's prescription and never self-adjust doses at home
from this filthy sewer, pure gold flows. We will be lucky if, one day, one might say that from the foul throat of the Gila monster and the filthy sewer of an anglerfish gut flowed one of natures most miraculous molecules
If the relationship isnt working, you can switch providers directly in the patient portal without calling support
Understanding this distinction helps explain why the 3-month results feel different from previous weight loss attempts
Unlike older weight-loss medications that simply suppress appetite through the central nervous system, GLP-1 agonists act on multiple pathways: Appetite regulation : They signal the brains satiety centre that you are full faster and for longer